Vaccines for human papillomavirus infection: A critical analysis.
Indian J Dermatol Venereol Leprol
;
2009 May-June; 75(3): 245-254
Artículo
en Inglés
| IMSEAR
| ID: sea-140344
ABSTRACT
This article takes a critical look at the pros and cons of human papillomavirus (HPV) vaccines. There is enough evidence to suggest that the prophylactic vaccines are efficacious in preventing various benign and malignant conditions (including cervical cancers) caused by HPV. Even though the vaccine is costly, hypothetical analysis has shown that HPV vaccination will be cost effective in the long run. Therapeutic HPV vaccines used to treat established disease are still undergoing evaluation in clinical studies, and results seem to be encouraging. Although several countries have started mandatory vaccination programs with the prophylactic HPV vaccines, conservatives have voiced concerns regarding the moral impact of such vaccination programs.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Idioma:
Inglés
Revista:
Indian J Dermatol Venereol Leprol
Año:
2009
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS